Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Petit

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Virology Journal|August 24, 2017
New insights into HCV replication in original cells from Aedes mosquitoesCatherine Fallecker, Alban Caporossi, Yassine Rechoum, et al.
Expert Review of Clinical Pharmacology|October 19, 2021
Pharmacological and safety profile of a prolonged-release lanreotide formulation in acromegalySebastian Neggers, Corin Badiu, Betina Biagetti, et al.
The Biochemical Journal|April 24, 2003
EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cellsStéphanie Charrin, François Le Naour, Valérie Labas, et al.
Clinics and Research in Hepatology and Gastroenterology|April 23, 2015
Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis casesMarie-Anne Petit, Pascale Berthillon, Pierre Pradat, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2018
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacyVictor Virlogeux, Pascale Berthillon, Isabelle Bordes, et al.
Cancer Letters|August 2, 2006
Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteinsOivier Galy, Marie-Anne Petit, Soumaya Benjelloun, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Virology Journal|August 24, 2017
New insights into HCV replication in original cells from Aedes mosquitoesCatherine Fallecker, Alban Caporossi, Yassine Rechoum, et al.
Expert Review of Clinical Pharmacology|October 19, 2021
Pharmacological and safety profile of a prolonged-release lanreotide formulation in acromegalySebastian Neggers, Corin Badiu, Betina Biagetti, et al.
The Biochemical Journal|April 24, 2003
EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cellsStéphanie Charrin, François Le Naour, Valérie Labas, et al.
Clinics and Research in Hepatology and Gastroenterology|April 23, 2015
Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis casesMarie-Anne Petit, Pascale Berthillon, Pierre Pradat, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2018
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacyVictor Virlogeux, Pascale Berthillon, Isabelle Bordes, et al.
Cancer Letters|August 2, 2006
Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteinsOivier Galy, Marie-Anne Petit, Soumaya Benjelloun, et al.
Pageof 3